119th Congress Health
H.R. 1620: Finn Sawyer Access to Cancer Testing Act
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Gus Bilirakis R-FLOriginal
- Don Bacon R-NEOriginal
- Donald Davis D-NCOriginal
- Raúl Grijalva D-AZOriginal
- James Himes D-CTOriginal
- Greg Landsman D-OHOriginal
- Terri Sewell D-ALOriginal
- Mike Thompson D-CAOriginal
- Rashida Tlaib D-MIOriginal
- Debbie Wasserman Schultz D-FLOriginal
- Josh Gottheimer D-NJ
- Paul Tonko D-NY
- Chellie Pingree D-ME
Who scored on this bill
- 1Doris Matsui SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Doris Matsui
History
- Introduced in the House by Doris Matsui.
Show the full action history (2 actions)
- Introduced in House
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.